Literature DB >> 3803476

M.I.T./Canadian vestibular experiments on the Spacelab-1 mission: 4. Space motion sickness: symptoms, stimuli, and predictability.

C M Oman, B K Lichtenberg, K E Money, R K McCoy.   

Abstract

Space sickness symptoms were observed by 4 specially trained observers on Spacelab-1. Three reported persistent symptoms, and vomited repeatedly during the first and/or second day of flight. Head movements on all axes were provocative, particularly in pitch and roll. Head acceleration data recorded from 2 symptomatic crewmen showed that after several hours of physical activity in orbit, symptoms appeared, and thereafter both crewmen were compelled to limit head movements. Firm body contact with motionless surfaces helped alleviate symptoms. When crewmembers floated into unfamiliar body orientations in the cabin, inherent ambiguities in static visual orientation cues sometimes produced spatial reorientation episodes which were also provocative. Symptoms largely resembled those of other forms of prolonged motion sickness, superimposed upon other symptoms attributable to fluid shift. All 4 eventually used anti-motion sickness drugs. When they did, vomiting frequency was reduced. By the 4th day, symptoms subsided, and head accelerations again increased in magnitude and variability. Sickness intensity in orbit was not predicted by statistically concordant results of 6 acute preflight susceptibility tests. However, results from a longer duration preflight prism goggles test showed an apparent correlation. All subjects were asymptomatic making head movements in parabolic flight 4 days after the mission, but not 1 year later. Overall, results support the view that space sickness is a motion sickness.

Entities:  

Keywords:  NASA Discipline Neuroscience; Non-NASA Center

Mesh:

Year:  1986        PMID: 3803476     DOI: 10.1007/bf00237749

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  26 in total

1.  Exposure-history as a factor in maintaining stability of perception and coordination.

Authors:  R HELD
Journal:  J Nerv Ment Dis       Date:  1961-01       Impact factor: 2.254

2.  GENERAL OBSERVATIONS ON SEA-SICKNESS AND THE LABYRINTHINE THEORY.

Authors:  T G Maitland
Journal:  Br Med J       Date:  1931-01-31

3.  Studies in space orientation; perception of the upright with displaced visual fields and with body tilted.

Authors:  S E ASCH; H A WITKIN
Journal:  J Exp Psychol       Date:  1948-08

4.  Visual counteraction on nauseogenic and disorienting effects of some whole-body motions: a proposed mechanism.

Authors:  F E Guedry
Journal:  Aviat Space Environ Med       Date:  1978-01

5.  Vestibular-induced vomiting after vestibulocerebellar lesions.

Authors:  A D Miller; V J Wilson
Journal:  Brain Behav Evol       Date:  1983       Impact factor: 1.808

6.  Perceived orientation in free-fall depends on visual, postural, and architectural factors.

Authors:  J R Lackner; A Graybiel
Journal:  Aviat Space Environ Med       Date:  1983-01

7.  Space motion sickness: phenomenology, countermeasures, and mechanisms.

Authors:  E I Matsnev; I Y Yakovleva; I K Tarasov; V N Alekseev; L N Kornilova; A D Mateev; G I Gorgiladze
Journal:  Aviat Space Environ Med       Date:  1983-04

8.  Inversion illusion in parabolic flight: its probable dependence on otolith function.

Authors:  A Graybiel; R S Kellogg
Journal:  Aerosp Med       Date:  1967-11

9.  Increased secretion of growth hormone, prolactin, antidiuretic hormone, and cortisol induced by the stress of motion sickness.

Authors:  T Eversmann; M Gottsmann; E Uhlich; G Ulbrecht; K von Werder; P C Scriba
Journal:  Aviat Space Environ Med       Date:  1978-01

10.  Motion sickness adaptation: a neural mismatch model.

Authors:  J T Reason
Journal:  J R Soc Med       Date:  1978-11       Impact factor: 18.000

View more
  17 in total

Review 1.  Space motion sickness.

Authors:  James R Lackner; Paul Dizio
Journal:  Exp Brain Res       Date:  2006-10-05       Impact factor: 1.972

2.  Locomotor function after long-duration space flight: effects and motor learning during recovery.

Authors:  Ajitkumar P Mulavara; Alan H Feiveson; James Fiedler; Helen Cohen; Brian T Peters; Chris Miller; Rachel Brady; Jacob J Bloomberg
Journal:  Exp Brain Res       Date:  2010-02-05       Impact factor: 1.972

3.  Gravity influences the visual representation of object tilt in parietal cortex.

Authors:  Ari Rosenberg; Dora E Angelaki
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

Review 4.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

5.  M.I.T./Canadian vestibular experiments on the Spacelab-1 mission: 1. Sensory adaptation to weightlessness and readaptation to one-g: an overview.

Authors:  L R Young; C M Oman; D G Watt; K E Money; B K Lichtenberg; R V Kenyon; A P Arrott
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  Illusions of verticality in weightlessness.

Authors:  H Mittelstaedt; S Glasauer
Journal:  Clin Investig       Date:  1993-09

7.  Effects of prolonged weightlessness on mental rotation of three-dimensional objects.

Authors:  Y Matsakis; M Lipshits; V Gurfinkel; A Berthoz
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

8.  Neurovestibular considerations for sub-orbital space flight: A framework for future investigation.

Authors:  Faisal Karmali; Mark Shelhamer
Journal:  J Vestib Res       Date:  2010       Impact factor: 2.435

9.  Egocentric references and human spatial orientation in microgravity. II. Body-centred coordinates in the task of drawing ellipses with prescribed orientation.

Authors:  V S Gurfinkel; F Lestienne; K E Popov; L Lefort
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Sensory conflict compared in microgravity, artificial gravity, motion sickness, and vestibular disorders.

Authors:  Jan E Holly; Sarah M Harmon
Journal:  J Vestib Res       Date:  2012-01-01       Impact factor: 2.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.